M.D. Gregory Berk - Pres. of R&D, CMO at GT Biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. of R&D, CMO
Issuer Symbol
GTBP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by M.D. Gregory Berk since 15 Feb 2025

Holdings reported by M.D. Gregory Berk for GT Biopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 278,058 $79,803 $0.2870 16 Feb 2021 Direct
Option to purchase Common Stock 50,000 15 Jul 2022 Direct Common Stock

Transactions reported by M.D. Gregory Berk for GT Biopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.